A recent study took advantage of mesoporous silica nanoparticles (MSNs) with EGFR-targeting aptamers; these nanoparticles interacted with circulating cancer-derived EGFR+ exosomes and eliminated these exosomes, causing their entry into the small intestine, which reduced the formation of metastasis [241]. The gene discussed is EGFR; the disease is cancer.